Róbert Wessman-led Aztiq and Innobic join forces in $475m acquisition of Lotus Pharmaceutical and Adalvo to create a global pharmaceutical powerhouse
- Written by PR Newswire
- The Aztiq-Innobic consortium will acquire a 100% stake in Alvogen Emerging Markets Holdings Limited, thereby becoming the leading shareholders in Lotus Pharmaceutical and the sole shareholder in Adalvo
- Róbert Wessman, chairman and CEO of Alvogen and founder of Aztiq, will continue as chairman of the board of Lotus and Adalvo.
- The...
